Abstract
A patient with diffuse angiokeratomas of the lower abdomen and genital region was diagnosed with Fabry disease on the basis of genetic testing. Fabry disease is an X-linked lysosomal storage disease that can affect several organ systems including the heart or kidneys, resulting in reduced median survival. Pathogenetically, Fabry disease leads to a deficiency of the lysosomal enzyme alpha-galactosidase A (alpha-GAL A). Treatment options include lifelong enzyme replacement therapy or chaperone therapy.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
ISSN: | 0020-9554 |
Sprache: | Deutsch |
Dokumenten ID: | 85096 |
Datum der Veröffentlichung auf Open Access LMU: | 25. Jan. 2022, 09:13 |
Letzte Änderungen: | 25. Jan. 2022, 09:13 |